Received Jul 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 92DJ3 | — |
vaccine was expired since 5/3/2025 and the patient received it today on 6/18/2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 5-day-old female patient who received HBV (Engerix B) (batch number 92DJ3, expiry date 03-MAY-2025) for prophylaxis. On 18-JUN-2025, the patient received Engerix B. On 18-JUN-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: vaccine was expired since 5/3/2025 and the patient received it today on 6/18/2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-JUN-2025 License practice nurse called to report that a 5 days old female patient received an expired dose of Engerix-B. The vaccine was expired since 5/3/2025 and the patient received it today on 6/18/2025. The reporter asked do we have to revaccinate the patient.